LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
ELI LILLY & Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1240.34−16.69 (-1.33%)
Close on Oct 19, 2026
- Market cap
- $1.11T
- P/E (TTM)
- 41.6
- Dividend yield
- 0.50%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$6.23
+15.4% on the prior year
Consecutive increases
9 years
Every year since FY2016
Dividend yield
0.50%
Latest annual dividend ÷ share price
Payout ratio, FY2025
26.1%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $6.23 | +15.4% | $5.38B | 26.1% |
| FY2024 | $5.40 | +15.1% | $4.68B | 44.2% |
| FY2023 | $4.69 | +15.2% | $4.07B | 77.7% |
| FY2022 | $4.07 | +15.3% | $3.54B | 56.6% |
| FY2021 | $3.53 | +15.0% | $3.09B | 55.3% |
| FY2020 | $3.07 | +14.6% | $2.69B | 43.4% |
| FY2019 | $2.68 | +15.0% | $2.41B | 29.0% |
| FY2018 | $2.33 | +9.9% | $2.31B | 71.5% |
| FY2017 | $2.12 | +3.4% | $2.19B | -1074.0% |
| FY2016 | $2.05 | – | $2.16B | 78.8% |
| FY2015 | – | – | $2.13B | 88.3% |
| FY2014 | – | – | $2.10B | 87.9% |
| FY2013 | – | – | $2.12B | 45.3% |
| FY2012 | – | – | $2.19B | 53.5% |
| FY2011 | $1.96 | 0.0% | $2.18B | 50.1% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.